TG-46

TargetMol
Product Code: TAR-T20743
Supplier: TargetMol
CodeSizePrice
TAR-T20743-1mg1mg£227.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-5mg5mg£416.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-10mg10mg£593.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-25mg25mg£962.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-50mg50mg£1,420.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T20743-100mg100mg£2,111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
TG-46 is an inhibitor of JAK2, JAK3, FLT3, and RET.
CAS:
936091-15-5
Formula:
C26H34N6O3S
Molecular Weight:
510.66
Pathway:
Chromatin/Epigenetic|Angiogenesis|Stem Cells|Tyrosine Kinase/Adaptors|JAK/STAT signaling
Purity:
0.98
SMILES:
Cc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1cccc(c1)S(=O)(=O)NC(C)(C)C
Target:
FLT|JAK

References

1. Kim EY, Lee JW, Lee MY, Kim SH, Mok HJ, Ha K, Ahn YM, Kim KP. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients. Psychiatry Res. 2018 Jul;265:174-182. doi: 10.1016/j.psychres.2018.04.029. Epub 2018 Apr 25. PubMed PMID: 29719272. 2. Belkoff L, Brock G, Carrara D, Neijber A, Ando M, Mitchel J. Efficacy and safety of testosterone replacement gel for treating hypogonadism in men: Phase III open-label studies. Andrologia. 2018 Feb;50(1). doi: 10.1111/and.12801. Epub 2017 Mar 10. PubMed PMID: 28295450. 3. Al Faris NA, Al Othman ZA, Ahmad D. Effects of Mesembrrybryanthemum forsskalei Hochst seeds in lowering glucose/lipid profile in streptozotocin-induced diabetic rats. J Food Sci Technol. 2011 Oct;48(5):616-21. doi: 10.1007/s13197-010-0152-8. Epub 2010 Nov 5. PubMed PMID: 23572796; PubMed Central PMCID: PMC3551122. 4. Quraishi SA, Schuler GH, Janicki PK. 5 HT(3)-receptor antagonists and cardiac repolarization time in patients expressing a novel genetic target associated with baseline QTc interval abnormalities. J Clin Anesth. 2011 Jun;23(4):297-302. doi: 10.1016/j.jclinane.2010.11.003. PubMed PMID: 21663814.